AIM IMMUNOTECH INC. Share-based Payment Arrangement, Expense
AIM IMMUNOTECH INC. (AIM) reported Share-based Payment Arrangement, Expense of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-07
- AIM IMMUNOTECH INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $0.00.
- AIM IMMUNOTECH INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. share-based payment arrangement, expense for fiscal 2020 was $433.00K, a 266.95% increase from fiscal 2019.
- AIM IMMUNOTECH INC. share-based payment arrangement, expense for fiscal 2019 was $118.00K, a 87.28% decline from fiscal 2018.
- AIM IMMUNOTECH INC. share-based payment arrangement, expense for fiscal 2018 was $928.00K, a 979.07% increase from fiscal 2017.
- AIM IMMUNOTECH INC. share-based payment arrangement, expense for fiscal 2017 was $86.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | ||||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | |||||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-17 | $0.00 derived: sum of 2 quarters · filed 2025-11-17 | $60.00K 10-Q · filed 2025-11-17 | |||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | $60.00K 10-Q · filed 2026-08-07 | ||||||
| 2025-03-31 | $60.00K 10-Q · filed 2026-05-15 | |||||||
| 2024-09-30 | $329.00K 10-Q · filed 2025-11-17 | $409.00K derived: sum of 2 quarters · filed 2025-11-17 | $490.00K 10-Q · filed 2025-11-17 | |||||
| 2024-06-30 | $80.00K 10-Q · filed 2025-08-14 | $160.00K 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | $80.00K 10-Q · filed 2025-05-15 | |||||||
| 2023-09-30 | $182.00K 10-Q · filed 2024-11-14 | |||||||
| 2020-12-31 | $433.00K 10-K · filed 2021-03-31 | |||||||
| 2019-12-31 | $118.00K 10-K · filed 2021-03-31 | $1.12M 10-K · filed 2020-03-30 | ||||||
| 2018-12-31 | $928.00K 10-K · filed 2020-03-30 | $145.00K 10-K · filed 2019-04-01 | ||||||
| 2018-06-30 | $326.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $612.00K 10-Q · filed 2018-08-14 | $412.00K derived: sum of 3 quarters · filed 2019-04-01 | $597.00K derived: sum of 4 quarters · filed 2019-04-01 | ||||
| 2018-03-31 | $286.00K 10-Q · filed 2018-05-15 | $86.00K derived: sum of 2 quarters · filed 2019-04-01 | $271.00K derived: sum of 3 quarters · filed 2019-04-01 | $320.00K derived: sum of 4 quarters · filed 2019-04-01 | ||||
| 2017-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$15.00K derived: sum of 2 quarters · filed 2019-04-01 | $34.00K derived: sum of 3 quarters · filed 2019-04-01 | $86.00K 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | $185.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $234.00K derived: sum of 2 quarters · filed 2018-08-14 | $286.00K 10-Q · filed 2017-11-14 | |||||
| 2017-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $101.00K 10-Q · filed 2018-08-14 | ||||||
| 2017-03-31 | $52.00K 10-Q · filed 2018-05-15 | |||||||
| 2016-09-30 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $292.00K derived: sum of 2 quarters · filed 2017-11-14 | $344.00K 10-Q · filed 2017-11-14 | $125.00K 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | $186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $238.00K 10-Q · filed 2017-08-14 | $238.00M 10-Q · filed 2016-08-15 | |||||
| 2016-03-31 | $52.00K 10-Q · filed 2017-05-15 | $52.00M 10-Q · filed 2016-05-16 | ||||||
| 2015-09-30 | -$110.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$57.85M derived: sum of 2 quarters · filed 2016-11-14 | $148.00K 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $53.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $111.00M 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | $58.00M 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | $223.00K 10-K · filed 2015-03-19 | |||||||
| 2013-12-31 | $219.00K 10-K · filed 2015-03-19 | |||||||
| 2012-12-31 | $271.00K 10-K · filed 2015-03-19 | $262.00K 10-K · filed 2013-03-18 | ||||||
| 2011-12-31 | $271.00K 10-K · filed 2014-03-14 | |||||||
| 2010-12-31 | $495.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |